Mindfulness to Enhance Cognitive Health in Latino Older Adults
Washington University School of Medicine · NCT07040904
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 65+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- December 10, 2024
- Record last updated
- May 11, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The primary objective of the proposed research is to investigate the promise and underlying mechanisms of mindfulness training as a preventative lifestyle intervention to enhance cognitive health in Latino older adults, thereby mitigating risk of Alzheimer's Disease (AD) in a population that may be particularly vulnerable.
Being studied: mindfulness
Conditions: Mindfulness; Alzheimer's Disease Related Dementia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Hispanic/Latino
- Age 65 and older
- Male, female, or non-binary
- Community living
- Medically stable and willing to undergo the study procedures
- No extensive mindfulness training experience
Exclusion Criteria
- Clinically unstable psychiatric disorder that requires immediate treatment (e.g., ECT)
- Medical conditions suggesting significantly shortened lifespan (e.g., metastatic cancer) or prohibiting safe participation in the interventions/assessments (e.g., Parkinson's disease, musculoskeletal conditions)
- Sensory impairment (hearing, vision) preventing participation
- Current alcohol or substance abuse
- Current/concurrent cognitive training known to affect neuroplasticity (e.g., brain-training programs), or other interventions expected to affect neuroplasticity significantly (e.g., psychedelics, cholinesterase inhibitors, high-dose sedatives).
Recruiting US locations
Washington University
St Louis, MO 63130
Site contact: Todd Braver · 314-935-5143 · tbraver@wustl.edu
Study contacts (from the official record)
- Todd S Braver, Ph.D. · 800-438-0445 · tbraver@wustl.edu
- Diana Parra Perez, Ph.D. · parrad@wustl.edu
Similar studies in Missouri
All neurology studies in Missouri →- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
University of Pennsylvania
- Location
- St Louis, MO + 2 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- St Louis, MO + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
Biohaven Therapeutics Ltd.
- Location
- Chesterfield, MO + 24 other US sites
- Eligibility basics
- Ages 40–80
- Recruiting
Diagnosing Epilepsy To EffeCT Change
Epiminder America, Inc.
- Location
- St Louis, MO + 21 other US sites
- Eligibility basics
- Ages 18–75